Poseida Therapeutics Inc.
9.50
0.00 (0.00%)
At close: Jan 07, 2025, 9:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -123.43M -64.00M -124.97M -129.78M -86.53M -44.40M -19.66M -4.58M
Depreciation & Amortization 5.61M 5.17M 4.55M 2.59M 1.19M 689.00K 676.00K 220.00K
Stock-Based Compensation 23.13M 18.93M 16.70M 7.22M 3.05M 975.00K 400.00K 303.00K
Other Working Capital 12.97M 29.55M 12.33M 9.79M 7.94M -286.00K -2.55M -6.38M
Other Non-Cash Items -11.57M -583.00K 639.00K 805.00K 7.64M 4.21M -1.73M 29.00K
Deferred Income Tax n/a n/a -19.63M 213.00K 784.00K -202.00K -528.00K -167.00K
Change in Working Capital 14.08M 13.71M 20.17M 5.62M 9.47M 718.00K -1.85M -5.72M
Operating Cash Flow -92.17M -26.77M -102.54M -113.33M -64.39M -38.01M -22.70M -9.99M
Capital Expenditures -3.07M -3.92M -2.63M -16.91M -5.16M -1.28M -201.00K -1.81M
Acquisitions n/a 12.00K 18.00K 187.52M 37.31M n/a n/a -550.00K
Purchase of Investments -237.80M -294.42M -18.00K -295.02M -71.44M n/a n/a n/a
Sales Maturities Of Investments 280.00M 95.00M 225.00M 107.50M 34.00M n/a n/a n/a
Other Investing Acitivies n/a -199.41M 18.00K -187.52M -37.31M n/a n/a n/a
Investing Cash Flow 39.13M -203.33M 222.38M -204.43M -42.59M -1.28M -201.00K -2.36M
Debt Repayment n/a 30.00M n/a n/a 10.00M 10.00M 10.00M n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 782.00K -140.00K 2.52M 108.20M 154.37M 44.07M 10.63M n/a
Financial Cash Flow 16.13M 105.16M 2.52M 313.94M 164.37M 54.07M 20.63M 8.59M
Net Cash Flow -36.91M -124.95M 122.36M -3.82M 57.39M 14.77M -2.27M -3.76M
Free Cash Flow -95.23M -30.70M -105.18M -130.24M -69.55M -39.30M -22.90M -11.80M

Create Price Alert on PSTX

Your price alert will notify you when the stock price is above 9.50.

Add to Watchlist